Stay updated on Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record for Sinovac’s quadrivalent influenza vaccine study in children is displayed, including its design, eligibility criteria, study locations, and safety and immunogenicity outcomes.SummaryDifference51%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA sitewide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs. The study record remains inaccessible.SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 error page, with its footer revision updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and navigation, effectively blocking access to the study information.SummaryDifference19%

- Check61 days agoChange DetectedA new revision label 'Revision: v3.7.0' was added, replacing the previous 'Revision: v3.6.6'. This indicates a version update for the page.SummaryDifference0.1%

Stay in the know with updates to Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page.